These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 27796029

  • 1. A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes.
    Yenilmez C, Ozdemir Koroglu Z, Kurt H, Yanas M, Colak E, Degirmenci I, Gunes HV.
    J Clin Pharm Ther; 2017 Feb; 42(1):103-107. PubMed ID: 27796029
    [Abstract] [Full Text] [Related]

  • 2. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
    Emingil G, Berdeli A, Gürkan A, Han Saygan B, Köse T, Atilla G.
    J Clin Periodontol; 2007 Apr; 34(4):278-84. PubMed ID: 17257155
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.
    Gürkan A, Emingil G, Saygan BH, Cinarcik S, Atilla G, Köse T, Berdeli A.
    J Periodontol; 2007 Jul; 78(7):1256-63. PubMed ID: 17608581
    [Abstract] [Full Text] [Related]

  • 5. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
    Saidi S, Slamia LB, Mahjoub T, Ammou SB, Almawi WY.
    J Stroke Cerebrovasc Dis; 2007 Jul; 16(4):153-9. PubMed ID: 17689411
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tissue plasminogen activator and plasminogen activator inhibitor type 1 gene polymorphism in patients with gastric ulcer complicated with bleeding.
    Kim HS, Hwang KY, Chung IK, Park SH, Lee MH, Kim SJ, Hong SY.
    J Korean Med Sci; 2003 Feb; 18(1):58-64. PubMed ID: 12589088
    [Abstract] [Full Text] [Related]

  • 8. Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study.
    Prabhudesai A, Shetty S, Ghosh K, Kulkarni B.
    Eur J Haematol; 2017 Sep; 99(3):249-254. PubMed ID: 28561456
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is not associated with breast cancer.
    Błasiak J, Smolarz B.
    Acta Biochim Pol; 2000 Sep; 47(1):191-9. PubMed ID: 10961693
    [Abstract] [Full Text] [Related]

  • 11. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism in Turkish adult patients with asthma.
    Cosan D, Kurt E, Kurt H, Degirmenci I, Kuçukarabaci B, Metintas M, Kucuk MU, Gunes HV, Colak E.
    Genet Test Mol Biomarkers; 2009 Aug; 13(4):543-6. PubMed ID: 19604112
    [Abstract] [Full Text] [Related]

  • 12. 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and insertion/deletion polymorphism of the tissue-type plasminogen activator gene in atherothrombotic stroke.
    Bang CO, Park HK, Ahn MY, Shin HK, Hwang KY, Hong SY.
    Cerebrovasc Dis; 2001 Aug; 11(4):294-9. PubMed ID: 11385207
    [Abstract] [Full Text] [Related]

  • 13. Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease.
    Espino A, Villagrán A, Vollrath V, Hanckes P, Salas R, Farah A, Solís N, Pizarro M, Escalona A, Boza C, Pérez G, Carrasco G, Padilla O, Miquel JF, Nervi F, Chavez-Tapia NC, Arab JP, Alvarez-Lobos M, Arrese M, Riquelme A.
    Ann Hepatol; 2011 Aug; 10(4):493-501. PubMed ID: 21911891
    [Abstract] [Full Text] [Related]

  • 14. Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer.
    Eroglu A, Ulu A, Cam R, Akar N.
    J BUON; 2006 Aug; 11(4):481-4. PubMed ID: 17309181
    [Abstract] [Full Text] [Related]

  • 15. Plasminogen activator inhibitor 1 (PAI-1) levels and gene promoter polymorphisms in subjects with colorectal cancer.
    Smolarz B, Blasiak J, Kulig A, Romanowicz-Makowska H, Dziki A, Ulanska J, Pander B, Szewczyk T.
    J Exp Clin Cancer Res; 2001 Jun; 20(2):247-52. PubMed ID: 11484982
    [Abstract] [Full Text] [Related]

  • 16. Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in Turkish children with asthma and allergic rhinitis.
    Ozbek OY, Ataç FB, Ogus E, Ozbek N.
    Allergy Asthma Proc; 2009 Jun; 30(1):41-6. PubMed ID: 19063817
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].
    Reshetniak TM, Ostriakova EV, Patrusheva NL, Patrushev LI, Aleksandrova EN, Seredavkina NV, Volkov AV, Nasonov EL.
    Ter Arkh; 2013 Jun; 85(1):76-84. PubMed ID: 23536951
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism and polycystic ovary syndrome.
    Kilicci C, Bayram B, Ozkurt M, Onlu H, Erkasap N, Mutlu F.
    Genet Test Mol Biomarkers; 2011 Jun; 15(7-8):565-7. PubMed ID: 21413876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.